ScholarIQanswers from OpenAlex
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
PaperCitations, authors & open-access status
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes have?
ScholarIQcitation count
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes has 6,387 citations in the OpenAlex counts ScholarIQ stores.
When was Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes published?
ScholarIQyear
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes has 2018 year in the ScholarIQ index.
What is the open-access status of Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes?
ScholarIQoa status
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes has bronze oa status in the ScholarIQ index.
What is the DOI of Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes?
ScholarIQdoi
The DOI for Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes is on the source record.
What is the PMID of Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes?
ScholarIQpmid
The PMID for Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes is on the source record.
What is the OpenAlex record for Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes?
ScholarIQopenalex
The OpenAlex for Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes is on the source record.